Yunnan University of Traditional Chinese Medicine Report issue

Academic/Hospital Phase 1 Phase 2

Organization Overview

First Clinical Trial
2014
NCT03591471
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Affiliated Hospital of Yunnan University | Affiliated Hospital of Yunnan University of Traditional Chinese Medicine | Yunnan University of Chinese Medicine

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

IgA Vasculitis (Phase 2)

Nephritis (Phase 2)

Purpura (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 4
  • # of Trial APIs: 11